Q. Ping Dou

Overview

Best Publications

• Connecting copper and cancer: from transition metal signalling to metalloplasia.

  Eva J Ge;Ashley I Bush;Angela Casini;Paul A Cobine

  1204
  Citations

• Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

  D. Chen;M. Frezza;S. Schmitt;J. Kanwar

  918
  Citations

• Broad targeting of resistance to apoptosis in cancer.

  Ramzi M. Mohammad;Irfana Muqbil;Leroy Lowe;Clement Yedjou

  900
  Citations

• Novel metals and metal complexes as platforms for cancer therapy.

  Michael Frezza;Sarmad Hindo;Di Chen;Andrew Davenport

  609
  Citations

• Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells.

  Shreelekha Adsule;Vivek Barve;Di Chen;Fakhara Ahmed

  441
  Citations

• Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells.

  Di Chen;Kenyon G. Daniel;Marina S. Chen;Deborah J. Kuhn

  405
  Citations

• Designing a broad-spectrum integrative approach for cancer prevention and treatment

  Keith I. Block;Charlotte Gyllenhaal;Leroy Lowe;Amedeo Amedei

  345
  Citations

• Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivo

  Vesna Milacic;Sanjeev Banerjee;Kristin R. Landis-Piwowar;Fazlul H. Sarkar

  336
  Citations

• Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

  Q. Ping Dou;Jeffrey A. Zonder

  314
  Citations

• A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.

  Kristin R. Landis-Piwowar;Congde Huo;Di Chen;Vesna Milacic

  301
  Citations

• Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor–Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and Xenografts

  Di Chen;Qiuzhi Cindy Cui;Huanjie Yang;Raul A. Barrea

  285
  Citations

• Androgen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer

  Ahmed O. Kaseb;Kannagi Chinnakannu;Di Chen;Arun Sivanandam

  281
  Citations

• EGCG, GREEN TEA POLYPHENOLS AND THEIR SYNTHETIC ANALOGS AND PRODRUGS FOR HUMAN CANCER PREVENTION AND TREATMENT

  Di Chen;Sheng Biao Wan;Huanjie Yang;Jian Yuan

  266
  Citations

• Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells.

  Boris Cvek;Vesna Milacic;Jan Taraba;Q. Ping Dou

  263
  Citations

• Tea polyphenols, their biological effects and potential molecular targets

  Di Chen;Vesna Milacic;Marina Si Chen;Sheng Biao Wan

  258
  Citations

• Metal complexes, their cellular targets and potential for cancer therapy.

  Di Chen;Vesna Milacic;Michael Frezza;Q. Ping Dou

  216
  Citations

• A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (−)-epigallocatechin gallate [(−)-EGCG]

  Wai Har Lam;Aslamuzzaman Kazi;Deborah J. Kuhn;Larry M.C. Chow

  197
  Citations

• Tumor Cellular Proteasome Inhibition and Growth Suppression by 8-Hydroxyquinoline and Clioquinol Requires Their Capabilities to Bind Copper and Transport Copper into Cells

  Shumei Zhai;Shumei Zhai;Lei Yang;Qiuzhi Cindy Cui;Ying Sun

  189
  Citations

• The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy

  Vesna Milacic;Q. Ping Dou

  187
  Citations

• Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo.

  Huanjie Yang;Ping Zhou;Hongbiao Huang;Di Chen

  182
  Citations